On Target Laboratories Inc., is in the business of discovering, developing and commercializing small molecules that, when conjugated with fluorescent dyes, target and illuminate specific cancerous cells and other diseased tissue. These conjugates can be used by doctors, including surgeons, worldwide to better diagnose and treat a wide range of diseases from cancer to inflammation-related disorders. OTL38 is currently under clinical development for use in ovarian and lung cancer surgery.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
03/14/18	$44,000,000	Series B	Elevate Ventures H.I.G. Capital Helsinn Investment Fund	undisclosed
11/16/23	$30,000,000	Series C	3B Future Health Fund Elevate Ventures H.I.G. Capital Johnson & Johnson Innovation Olympus Innovation Ventures Pension Fund of the Christian Church The Hurvis Group	undisclosed